Company research
OMNICELL, INC.
CIK 926326Updated Sep 24, 2026
SecurityOMCL · NASDAQ · equity
Name history
OMNICELL, Inc · through Jun 22, 2022OMNICELL INC /CA/ · through Apr 10, 2007OMNICELL COM /CA/ · through Mar 9, 2001
OMCL price & chart
Loading TradingView…
NASDAQ:OMCL on TradingView ↗About the company
Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, Omnicell empowers autonomous medication management by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that improve efficiency and enhance patient safety for healthcare facilities worldwide. Learn more at omnicell.com.
In the news
No coverage from other publishers is available.
Recent filings
144 filing
SCHEDULE 13G/A filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
144 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,974,720,000Source | 2,120,960,000Source | 2,226,878,000Source | 2,210,758,000Source |
| Property, Plant and Equipment, NetUSD | 120,111,000Source | 112,692,000Source | 108,601,000Source | 93,961,000Source |
| GoodwillUSD | 737,946,000Source | 734,727,000Source | 735,810,000Source | 734,274,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 170,105,000Source | 188,266,000Source | 211,173,000Source | 242,906,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 196,520,000Source | 369,201,000Source | 467,972,000Source | 330,362,000Source |
| Inventory, NetUSD | 100,905,000Source | 88,659,000Source | 110,099,000Source | 147,549,000Source |
| Assets, CurrentUSD | 680,069,000Source | 815,493,000Source | 927,571,000Source | 881,812,000Source |
| Operating Lease, Right-of-Use AssetUSD | 24,366,000Source | 25,607,000Source | 24,988,000Source | 38,052,000Source |
| Other Assets, NoncurrentUSD | 70,204,000Source | 79,306,000Source | 90,466,000Source | 105,017,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 742,906,000Source | 877,647,000Source | 1,037,924,000Source | 1,080,621,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 58,000Source | 57,000Source | 56,000Source | 55,000Source |
| Additional Paid in CapitalUSD | 1,223,977,000Source | 1,167,882,000Source | 1,122,292,000Source | 1,046,760,000Source |
| Retained Earnings (Accumulated Deficit)USD | 384,940,000Source | 382,888,000Source | 370,357,000Source | 390,728,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -8,854,000Source | -17,195,000Source | -13,432,000Source | -17,087,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,231,814,000Source | 1,243,313,000Source | 1,188,954,000Source | 1,130,137,000Source |
| Liabilities and EquityUSD | 1,974,720,000Source | 2,120,960,000Source | 2,226,878,000Source | 2,210,758,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 476,609,000Source | 595,678,000Source | 367,792,000Source | 428,446,000Source |
| Operating Lease, Liability, CurrentUSD | 11,955,000Source | 10,702,000Source | 10,518,000Source | 10,761,000Source |
| Accounts Payable, CurrentUSD | 43,990,000Source | 51,782,000Source | 45,028,000Source | 63,389,000Source |
| Operating Lease, Liability, NoncurrentUSD | 24,794,000Source | 31,123,000Source | 33,910,000Source | 39,405,000Source |
| Deferred Income Tax Liabilities, NetUSD | 683,000Source | 1,108,000Source | 1,620,000Source | 2,095,000Source |
| Other Liabilities, NoncurrentUSD | 9,970,000Source | 7,218,000Source | 6,318,000Source | 6,719,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 203,586,000Source | 167,895,000Source | 149,276,000Source | 172,655,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 78,795,000Source | 82,232,000Source | 87,319,000Source | 86,931,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 44,502,000Source | 39,316,000Source | 55,300,000Source | 68,247,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | 60,357,000Source |
| Increase (Decrease) in InventoriesUSD | 11,225,000Source | -15,633,000Source | -38,016,000Source | 30,115,000Source |
| Increase (Decrease) in Accounts PayableUSD | -9,283,000Source | 7,210,000Source | -17,525,000Source | -7,754,000Source |
| Deferred Income Tax Expense (Benefit)USD | -508,000Source | -14,553,000Source | -10,604,000Source | -34,290,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 127,300,000Source | 187,722,000Source | 181,094,000Source | 77,781,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | 0Source | 0Source | 3,392,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -60,363,000Source | -52,793,000Source | -55,016,000Source | -58,669,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 40,415,000Source | 36,463,000Source | 41,474,000Source | 47,536,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 7,684,000Source | 4,827,000Source | 7,366,000Source | 13,506,000Source |
| Payments for Repurchase of Common StockUSD | 77,600,000Source | 0Source | 0Source | 52,210,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -218,317,000Source | -235,578,000Source | 23,420,000Source | -20,953,000Source |
| Repayments of Long-term DebtUSD | — | — | — | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -147,582,000Source | -102,365,000Source | 148,144,000Source | -2,785,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 251,032,000Source | 398,614,000Source | 500,979,000Source | 352,835,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 2,201,000Source | 1,624,000Source | 1,438,000Source | 1,438,000Source |
| Income Taxes Paid, NetUSD | 18,410,000Source | 11,279,000Source | 20,209,000Source | 19,005,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 3,798,000Source | -1,716,000Source | -1,354,000Source | -944,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 44,502,000Source | 39,316,000Source | 55,300,000Source | 68,247,000Source |
| Amortization of Debt Issuance CostsUSD | 2,651,000Source | 3,788,000Source | 4,397,000Source | 4,164,000Source |
| Amortization of Intangible AssetsUSD | 21,600,000Source | 22,800,000Source | 31,600,000Source | 35,200,000Source |
| Capitalized Computer Software, AmortizationUSD | 23,100,000Source | 24,900,000Source | 28,700,000Source | 29,000,000Source |
| DepreciationUSD | 35,400,000Source | 34,500,000Source | 27,000,000Source | 22,800,000Source |
| Gain (Loss) on Disposition of AssetsUSD | -488,000Source | -978,000Source | -2,572,000Source | -678,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 7,517,000Source | — | — |
| GoodwillUSD | 737,946,000Source | 734,727,000Source | 735,810,000Source | 734,274,000Source |
| Income Tax Expense (Benefit)USD | 9,273,000Source | 13,062,000Source | 263,000Source | -8,101,000Source |
| Inventory Write-downUSD | 0Source | 5,393,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | 2,052,000Source | 12,531,000Source | -20,371,000Source | 5,648,000Source |
| Nonoperating Income (Expense)USD | 6,165,000Source | 25,256,000Source | 14,760,000Source | -130,000Source |
| Operating ExpensesUSD | 498,282,000Source | 470,666,000Source | 531,708,000Source | 591,310,000Source |
| Operating Lease, Impairment LossUSD | 0Source | 0Source | 9,998,000Source | 9,382,000Source |
| Operating Lease, Lease IncomeUSD | — | 3,649,000Source | 6,591,000Source | 9,460,000Source |
| Restructuring CostsUSD | — | — | — | 22,803,000Source |
| Sales-type Lease, Selling Profit (Loss)USD | 12,661,000Source | 13,106,000Source | 18,115,000Source | 19,600,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,184,845,000Source | 1,112,238,000Source | 1,147,112,000Source | 1,295,947,000Source |
| Cost of RevenueUSD | 681,403,000Source | 641,235,000Source | 650,272,000Source | 706,960,000Source |
| Selling, General and Administrative ExpenseUSD | 409,610,000Source | 380,254,000Source | 434,593,000Source | 486,341,000Source |
| Operating Income (Loss)USD | 5,160,000Source | 337,000Source | -34,868,000Source | -2,323,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 11,325,000Source | 25,593,000Source | -20,108,000Source | -2,453,000Source |
| Income Tax Expense (Benefit)USD | 9,273,000Source | 13,062,000Source | 263,000Source | -8,101,000Source |
| Net Income (Loss) Attributable to ParentUSD | 2,052,000Source | 12,531,000Source | -20,371,000Source | 5,648,000Source |
| Earnings Per Share, BasicUSD per share | 0.04Source | 0.27Source | -0.45Source | 0.13Source |
| Earnings Per Share, DilutedUSD per share | 0.04Source | 0.27Source | -0.45Source | 0.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 45,965,000Source | 46,047,000Source | 45,212,000Source | 44,398,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 46,362,000Source | 46,255,000Source | 45,212,000Source | 45,891,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 21,600,000Source | 22,800,000Source | 31,600,000Source | 35,200,000Source |
| Capitalized Computer Software, AmortizationUSD | 23,100,000Source | 24,900,000Source | 28,700,000Source | 29,000,000Source |
| Current Income Tax Expense (Benefit)USD | 9,781,000Source | 27,615,000Source | 10,867,000Source | 26,189,000Source |
| Gross ProfitUSD | 503,442,000Source | 471,003,000Source | 496,840,000Source | 588,987,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 10,154,000Source | 19,757,000Source | -28,105,000Source | 369,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | 11,900,000Source | 24,900,000Source | — | — |
| Nonoperating Income (Expense)USD | 6,165,000Source | 25,256,000Source | 14,760,000Source | -130,000Source |
| Operating ExpensesUSD | 498,282,000Source | 470,666,000Source | 531,708,000Source | 591,310,000Source |
| Operating Lease, Lease IncomeUSD | — | 3,649,000Source | 6,591,000Source | 9,460,000Source |
| Research and Development ExpenseUSD | 88,672,000Source | 90,412,000Source | 97,115,000Source | 104,969,000Source |
| Restructuring and Related Cost, Incurred CostUSD | — | 6,600,000Source | — | — |
| Restructuring CostsUSD | — | — | — | 22,803,000Source |
| Sales-type Lease, Selling Profit (Loss)USD | 12,661,000Source | 13,106,000Source | 18,115,000Source | 19,600,000Source |
Filing attachments
tm2619353d1_ex99-1.htm · 8-K · 2026-07-01
EX-99.1 2 tm2619353d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Betsy Martinelli Director, Corporate Marketing betsy.martinelli@omnicell.com Nnamdi Njoku Appointed President of Omnicell Njoku continues to lead global operations and advance Omnicell's innovation and AI platform strategy; Randall Lipps continues to serve as Chief Executive Officer and Chairman of the Board Fort Worth, Texas - July 1, 2026 - Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading health…
Read attachment ↗tm2532894d1_ex99-1.htm · 8-K · 2025-12-08
EX-99.1 2 tm2532894d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Betsy Martinelli Director, Corporate Marketing betsy.martinelli@omnicell.com Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise Fort Worth, Texas - December 8, 2025 - Omnic…
Read attachment ↗tm2524232d1_ex99-1.htm · 8-K · 2025-08-25
EX-99.1 2 tm2524232d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 For more information, contact: Kathleen Nemeth Senior Vice President, Investor Relations Kathleen. Nemeth@omnicell.com 650-435-3318 Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer Seasoned leader brings more than 30 years of experience driving growth for healthcare and technology companies FORT WORTH, Texas, -- August 25, 2025 - Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”…
Read attachment ↗tm2515763d1_ex99-1.htm · 8-K · 2025-05-22
EX-99.1 2 tm2515763d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Kathleen Nemeth Omnicell, Inc. Senior Vice President, Investor Relations 4220 North Freeway 650-435-3318 Fort Worth, TX 76137 Kathleen. Nemeth@Omnicell.com Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program FORT WORTH, Texas -- May 22, 2025 -- Omnicell,…
Read attachment ↗tm258643d1_ex99-1.htm · 8-K · 2025-03-12
EX-99.1 2 tm258643d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Kathleen Nemeth Omnicell, Inc. Senior Vice President, Investor 4220 North Freeway Relations 650-435-3318 Fort Worth, TX 76137 Kathleen. Nemeth@Omnicell.com Omnicell Announces Chief Financial Officer Transition Company Reiterates First Quarter and Full Year 2025 Guidance FORT WORTH, Texas - March 12, 2025 -- Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,”…
Read attachment ↗tm255146d1_ex99-1.htm · 8-K · 2025-02-06
EX-99.1 2 tm255146d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Kathleen Nemeth Omnicell, Inc. Senior Vice President, Investor Relations 4220 North Freeway 650-435-3318 Fort Worth, TX 76137 Kathleen. Nemeth@Omnicell.com Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results Omnicell delivers strong fourth quarter financial results Results exceed previously issued full year guidance for bookings, to…
Read attachment ↗